Impact of upgrade to cardiac resynchronization therapy on ventricular arrhythmia frequency in patients with implantable cardioverter-defibrillators

Cengiz Ermis, Ryan Seutter, Alan X. Zhu, Lauren C. Benditt, Laura VanHeel, Scott Sakaguchi, Keith G. Lurie, Fei Lu, David G. Benditt

Research output: Contribution to journalArticlepeer-review

90 Scopus citations

Abstract

OBJECTIVES: This study compared cardiac resynchronization therapy's (CRT) impact on ventricular tachyarrhythmia susceptibility in patients who, due to worsening heart failure (HF) symptoms, underwent a replacement of a conventional implantable cardioverter-defibrillator (ICD) with a CRT-ICD. BACKGROUND: Cardiac resynchronization therapy is an effective addition to conventional treatment of HF in many patients with left ventricular systolic dysfunction. However, whether CRT-induced improvements in HF status also reduce susceptibility to life-threatening arrhythmias is less certain. METHODS: Clinical and ICD electrogram data were evaluated in 18 consecutive ICD patients who underwent an upgrade to CRT-ICD. Pharmacologic HF therapy was not altered during follow-up. The definition of ventricular tachycardia (VT) and ventricular fibrillation (VF) for each patient was as determined by device programming. Statistical comparisons used paired t tests. RESULTS: Findings were recorded during two time periods: 47 ± 21 months (range 24 to 70 months) before and 14 ± 2 months (range 9 to 18 months) after CRT upgrade. At time of upgrade, patient age was 69 ± 11 years and ejection fraction was 21 ± 8%. Before CRT the frequency of VT, VF, and appropriate ICD shocks was 0.31 ± 1.23, 0.047 ± 0.083, and 0.048 ± 0.085 episodes/month/patient, respectively. After CRT-ICD, VT and VF arrhythmia burdens and frequency of shocks were respectively 0.13 ± 0.56, 0.001 ± 0.004, and 0.003 ± 0.016 episodes/month/patient (p = 0.59, 0.03, and 0.05 vs. pre-CRT). CONCLUSIONS: Arrhythmia frequency and number of appropriate ICD treatments were reduced after upgrade to CRT-ICD for HF treatment. Thus, apart from hemodynamic benefits, CRT may also ameliorate ventricular tachyarrhythmia susceptibility in HF patients.

Original languageEnglish (US)
Pages (from-to)2258-2263
Number of pages6
JournalJournal of the American College of Cardiology
Volume46
Issue number12
DOIs
StatePublished - Dec 20 2005

Bibliographical note

Funding Information:
This work was supported by a grant from the Cardiac Arrhythmia Center at the University of Minnesota, Minneapolis, Minnesota. Dr. Ermis was supported in part by the Midwest Arrhythmia Research Foundation, Edina, Minnesota. Dr. Benditt is a consultant and shareholder for Medtronic Inc., and St. Jude Medical Inc. Dr. Lurie is a consultant and shareholder for St. Jude Medical Inc.

Fingerprint Dive into the research topics of 'Impact of upgrade to cardiac resynchronization therapy on ventricular arrhythmia frequency in patients with implantable cardioverter-defibrillators'. Together they form a unique fingerprint.

Cite this